编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
121805 | L-778123 hydrochloride | 253863-00-2 | 98% | |
L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and | ||||
2073106 | Lerociclib HCl (G1T38 HCl) | 2097938-59-3 | ≧98.0% | |
Lerociclib HCl (G1T38 dihydrochloride)是一种分化型口服CDK4 / 6抑制剂,对 | ||||
S510902 | Cenicriviroc ( TAK-652 ) | 497223-25-3 | 98% Min. | |
Cenicriviroc(TAK-652, TBR-652) 是一种CCR2和CCR5受体抑制剂,临床上它被用 | ||||
1711222 | Asciminib ( ABL001 ) | 1492952-76-7 | 99.35% | |
Asciminib, 也叫ABL001,是一种有效的BCR-ABL的变构抑制剂。ABL001在与尼 | ||||
18381 | JPH203 HCl ( Nanvuranlat ) | 1597402-27-1 | ≧95.0% | |
JPH203,也称为KYT- 0353,是一个强有力的和选择性(l型氨基酸转运蛋白 | ||||
18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | |
Ritlecitinib ( PF-06651600 )是一种有效的选择性JAK3抑制剂,是一种具有 | ||||
184321 | Ensartinib ( X396 ) | 1370651-20-9 | >98% | |
Ensartinib is an orally available small molecule inhibitor of the receptor tyrosine k | ||||
512194 | Lazertinib | 1903008-80-9 | 98% Min. | |
Description:Lazertinib is a an orally available third-generation, selective inhibi | ||||
185235 | Trilaciclib (G1T28) | 1374743-00-6 | >98% | |
Trilaciclib是一种小分子竞争性细胞周期蛋白依赖性激酶4和6(CDK4 / | ||||
18722 | Fezolinetant | 1629229-37-3 | >98% | |
Fezolinetant,也被称为ESN-364,是一种神经kinin-3 (NK-3)受体拮抗剂,已 | ||||
187122 | Gefapixant | 1015787-98-0 | 98% | |
Gefapixant (MK-7264) 是一个口服的、P2X3 受体活性拮抗剂,其对人同源 | ||||
188281 | Arimoclomol maleate | 289893-26-1 | 98% | |
Arimoclomol,也被称为BRX-220,能够潜在有用的治疗Niemann-Pick疾病C型 |